COMP <GO>
CTRN vs SHOE // EV/EBITDA & P/E VALUATION
Citi Trends Inc. (NASDAQ) VS. Shoe Station Group Inc. (NASDAQ) • 15-METRIC TALLY: CTRN 3
— SHOE 9
▲ EV/EBITDA & P/E VALUATION LEADER: SHOE
LAST: $48.54 (+6.94%) • MKT CAP: $404.8M
valuation
105.1x
LAST: $15.07 (+4.29%) • MKT CAP: $409.7M
valuation
2.8x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CTRN VS. SHOE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CTRN | SHOE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 36.60% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 2.60% | 9.20% | -6.60 | SHOE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 105.1x | 2.8x | +102.30 | SHOE | /valuation <GO> |
| Free Cash Flow Yield | 5.18% | 6.49% | -1.31 | SHOE | /fcf-yield <GO> |
| Operating Margin | 0.50% | 5.90% | -5.40 | SHOE | /operating-margins <GO> |
| Net Profit Margin | 0.60% | 4.60% | -4.00 | SHOE | /net-margins <GO> |
| Revenue Growth (YoY) | 8.90% | -5.60% | +14.50 | CTRN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 4.09% | -4.09 | SHOE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.34 | 2.99 | +0.35 | CTRN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 6/9 | +1.00 | CTRN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.3 | 61.3 | -16.98 | SHOE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 72.4x | 7.3x | +65.10 | SHOE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $404.8M | $409.7M | -$4.9M | SHOE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CTRN REV | SHOE REV | CTRN GROSS % | SHOE GROSS % | CTRN FCF | SHOE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $820.0M | $1.14B | — | 36.6% | $21.0M | $26.6M |
| FY 2024 | $753.1M | $1.20B | — | 35.6% | -$3.8M | $69.5M |
| FY 2023 | $747.9M | $1.18B | — | — | -$9.6M | $122.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CTRN // BETA —
SHOE // BETA —